IS7467A - Lansóprasólfjölgervingar og aðferðir við að framleiða þá - Google Patents

Lansóprasólfjölgervingar og aðferðir við að framleiða þá

Info

Publication number: IS7467A
Authority: IS; Iceland
Prior art keywords: lansoprazole; producing; methods; multiple synthesis; synthesis
Prior art date: 2002-03-27

Application number

IS7467A

Other languages

English (en)

Inventor

Finkelstein Nina

Wizel Shlomit

Original Assignee

Teva Pharmaceutical Industries Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-27

Filing date

2004-09-23

Publication date

2004-09-23

2004-09-23 Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.

2004-09-23 Publication of IS7467A publication Critical patent/IS7467A/is

Links

230000015572 biosynthetic process Effects 0.000 title 1
MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 title 1
229960003174 lansoprazole Drugs 0.000 title 1
238000000034 method Methods 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IS7467A 2002-03-27 2004-09-23 Lansóprasólfjölgervingar og aðferðir við að framleiða þá IS7467A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US36782002P	2002-03-27	2002-03-27
PCT/US2003/009261 WO2003082857A2 (en)	2002-03-27	2003-03-27	Lansoprazole polymorphs and processes for preparation thereof

Publications (1)

Publication Number	Publication Date
IS7467A true IS7467A (is)	2004-09-23

Family

ID=28675405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7467A IS7467A (is)	2002-03-27	2004-09-23	Lansóprasólfjölgervingar og aðferðir við að framleiða þá

Country Status (15)

Country	Link
US (1)	US20040010151A1 (is)
EP (1)	EP1476442A2 (is)
JP (1)	JP2005533755A (is)
KR (1)	KR20040093187A (is)
CN (1)	CN1681802A (is)
AU (1)	AU2003224779A1 (is)
CA (1)	CA2480352A1 (is)
HR (1)	HRP20040979A2 (is)
IL (1)	IL164153A0 (is)
IS (1)	IS7467A (is)
MX (1)	MXPA04009384A (is)
NO (1)	NO20044606L (is)
PL (1)	PL373539A1 (is)
WO (1)	WO2003082857A2 (is)
ZA (1)	ZA200407799B (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) *	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) *	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US8697094B2 (en) *	2002-10-16	2014-04-15	Takeda Pharmaceutical Company Limited	Stable solid preparations
US8592598B2 (en)	2004-09-13	2013-11-26	Takeda Pharmaceutical Company Limited	Method of producing a crystal of an imidazole compound
EP1681056A1 (en) *	2005-01-14	2006-07-19	Krka Tovarna Zdravil, D.D., Novo Mesto	Process for preparing lansoprazole
KR100758600B1 (ko) *	2006-01-05	2007-09-13	주식회사 대웅제약	란소프라졸 결정형 ａ의 제조방법
JP2008543953A (ja) *	2006-04-20	2008-12-04	テバファーマシューティカルインダストリーズリミティド	エスゾピクロン結晶形態ａ、実質的に純粋なエスゾピクロン及び光学的に豊富なエスゾピクロンを調製するための方法
US20100093804A1 (en) *	2006-12-07	2010-04-15	Hetero Drugs Limited	novel crystalline form of lansoprazole
AU2007341992B2 (en)	2006-12-29	2012-07-05	Il Yang Pharmaceutical Company, Ltd.	Crystalline forms of solvated ilaprazole
IT1391758B1 (it) *	2008-11-11	2012-01-27	Dipharma Francis Srl	Procedimento per la preparazione di dexlansoprazolo amorfo
IT1392813B1 (it)	2009-02-06	2012-03-23	Dipharma Francis Srl	Forme cristalline di dexlansoprazolo
KR20100101405A (ko) *	2009-03-09	2010-09-17	한미홀딩스 주식회사	비결정형의 (+)-란소프라졸 제조방법 및 이에 사용되는 (+)-란소프라졸 알코올레이트
WO2011004387A2 (en) *	2009-06-18	2011-01-13	Matrix Laboratories Ltd	Process for the preparation of dexlansoprazole polymorphic forms
CN102108076B (zh) *	2009-12-23	2014-07-23	江苏豪森医药集团有限公司	制备无定形右兰索拉唑的方法
US8853411B2 (en)	2010-03-31	2014-10-07	Ranbaxy Laboratories Limited	Process for the preparation of dexlansoprazole
EP2663306A4 (en) *	2011-01-12	2014-01-01	Hetero Research Foundation	POLYMORPHS OF DEXLANSOPRAZOLE SALTS
TWI665190B (zh)	2013-11-15	2019-07-11	阿克比治療有限公司	｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途
CN103664889B (zh) *	2013-12-19	2014-11-19	悦康药业集团有限公司	一种兰索拉唑化合物
CN104844576B (zh) *	2015-04-28	2017-03-08	山东罗欣药业集团股份有限公司	一种兰索拉唑或右旋兰索拉唑晶型化合物及其制备方法
CN104829594A (zh) *	2015-05-15	2015-08-12	苗怡文	一种治疗胃溃疡的药物兰索拉唑化合物
CN104958276A (zh) *	2015-07-30	2015-10-07	青岛蓝盛洋医药生物科技有限责任公司	一种治疗胃溃疡的药物兰索拉唑组合物胶囊
CN104997738A (zh) *	2015-08-10	2015-10-28	青岛蓝盛洋医药生物科技有限责任公司	一种治疗胃病的药物兰索拉唑组合物干混悬剂
CN107011328B (zh) *	2017-05-05	2019-10-15	广州大光制药有限公司	一种兰索拉唑化合物的晶型及其结晶制备方法
CN108794450B (zh) *	2018-07-24	2022-08-19	浙江恒康药业股份有限公司	制备无定型右旋兰索拉唑的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK171989B1 (da) *	1987-08-04	1997-09-08	Takeda Chemical Industries Ltd	Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
TW385306B (en) *	1996-11-14	2000-03-21	Takeda Chemical Industries Ltd	Method for producing crystals of benzimidazole derivatives
TWI275587B (en) *	1999-06-17	2007-03-11	Takeda Chemical Industries Ltd	A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) *	1999-06-18	2001-01-02	Inst Farmaceutyczny	Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
DE60020967T2 (de) *	1999-06-30	2006-05-04	Takeda Pharmaceutical Co. Ltd.	Kristalle von lansoprazole
KR20100002278A (ko) *	2000-12-01	2010-01-06	다케다 야쿠힌 고교 가부시키가이샤	(ｒ)- 또는 (ｓ)-란소프라졸의 결정
CZ20032351A3 (cs) *	2001-02-02	2004-08-18	Tevaápharmaceuticaláindustriesáltd	Způsob výroby substituovaných @@}@@pyridylmethylB sulfinyl @�H@benzimidazolů

2003
- 2003-03-27 CA CA002480352A patent/CA2480352A1/en not_active Abandoned
- 2003-03-27 AU AU2003224779A patent/AU2003224779A1/en not_active Abandoned
- 2003-03-27 WO PCT/US2003/009261 patent/WO2003082857A2/en not_active Ceased
- 2003-03-27 US US10/401,057 patent/US20040010151A1/en not_active Abandoned
- 2003-03-27 IL IL16415303A patent/IL164153A0/xx unknown
- 2003-03-27 PL PL03373539A patent/PL373539A1/xx not_active Application Discontinuation
- 2003-03-27 MX MXPA04009384A patent/MXPA04009384A/es not_active Application Discontinuation
- 2003-03-27 HR HR20040979A patent/HRP20040979A2/hr not_active Application Discontinuation
- 2003-03-27 KR KR10-2004-7015088A patent/KR20040093187A/ko not_active Ceased
- 2003-03-27 CN CNA038120372A patent/CN1681802A/zh active Pending
- 2003-03-27 EP EP03721469A patent/EP1476442A2/en not_active Withdrawn
- 2003-03-27 JP JP2003580323A patent/JP2005533755A/ja active Pending
2004
- 2004-09-23 IS IS7467A patent/IS7467A/is unknown
- 2004-09-28 ZA ZA200407799A patent/ZA200407799B/en unknown
- 2004-10-26 NO NO20044606A patent/NO20044606L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2003224779A1 (en)	2003-10-13
KR20040093187A (ko)	2004-11-04
CN1681802A (zh)	2005-10-12
IL164153A0 (en)	2005-12-18
EP1476442A2 (en)	2004-11-17
WO2003082857A3 (en)	2003-12-18
US20040010151A1 (en)	2004-01-15
JP2005533755A (ja)	2005-11-10
CA2480352A1 (en)	2003-10-09
ZA200407799B (en)	2006-07-26
MXPA04009384A (es)	2005-01-25
HRP20040979A2 (en)	2005-06-30
WO2003082857A2 (en)	2003-10-09
PL373539A1 (en)	2005-09-05
NO20044606L (no)	2004-10-26

Publication	Publication Date	Title
NO20031776L (no)	2003-10-20	Null-boringskomplettering og produksjonssystem
IS8061A (is)	2005-10-05	Kerfi og aðferð við að framleiða sérsniðna fóðringu fyrir gervilimi
CY2015015I1 (el)	2020-05-29	Παραγωγη τιακουμυκινης
NO20055633D0 (no)	2005-11-29	Oralt snusprodukt og fremgangsmate for a fremstille snusproduktet
ATE298778T1 (de)	2005-07-15	Fischer-tropsch-syntheseverfahren
IS7645A (is)	2005-01-12	Stillar glúkósteraviðtaka og aðferð
IS7369A (is)	2004-07-23	Aðferð og tæki til örflögunýmyndunar
IS7725A (is)	2005-03-04	Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra
NO20043902L (no)	2004-09-17	Kontrollert syntese av ziprasidon og sammensetninger derav
NO20055211D0 (no)	2005-11-04	Anti-fungale forbindelser og fremgangsmater for anvendelse
DK1641832T3 (da)	2019-06-24	Fremgangsmåde til fremstilling af fiberholdig pektin og produkter og anvendelser heraf
DK1713544T3 (da)	2009-11-16	Sammensætninger og fremgangsmåder til oral og personlig pleje
IS7351A (is)	2004-07-13	Kristölluð karvedílól á föstu formi og aðferðir til að framleiða þau
NO20034283L (no)	2004-03-29	Fremgangsmate og anordning for fremstilling av syntesegass
NO20043032L (no)	2004-09-28	Fremgangsmate og anordning for fremstilling av borstehar
NO20034282D0 (no)	2003-09-25	Fremgangsmåte og anordning for fremstilling av syntesegass
NO20033854L (no)	2003-10-28	N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
IS2775B (is)	2012-03-15	Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra
DK2305689T3 (da)	2014-07-14	Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser
IS7402A (is)	2004-08-13	Ný kristölluð form atorvastatínhálfkalsíums og aðferðir til að framleiða þau, auk nýrra aðferða tilað framleiða atorvastatínhálfkalsíum form I, VIIIog IX
NO20011026D0 (no)	2001-02-28	Matvare og fremgangsmÕte for fremstilling derav
ATE517893T1 (de)	2011-08-15	Arylvinylazacycloalkan-verbindungen sowie herstellungsverfahren dafür und verwendung davon
DK1589938T3 (da)	2011-03-14	Mundplejesammensætninger og fremgangsmåder hertil
PL394821A1 (pl)	2011-09-12	Sposób wytwarzania kombrestatyn
DK1572950T3 (da)	2013-02-04	Enkeltdomæne TDF-relaterede forbindelser og analoger deraf